A novel predictor of clinical progression in patients on active surveillance for prostate cancer.

CONCLUSIONS: TCLo density is able to stratify patients on AS for risk of CP and GP. With further validation, it could be added to the decision-making algorithm in AS for low-risk localized PCa.
PMID: 31496491 [PubMed]

Source: Canadian Urological Association Journal - July 31, 2019 Category: Urology & Nephrology Authors: Tan GH, Finelli A, Ahmad A, Wettstein MS, Chandrasekar T, Zlotta AR, Fleshner NE, Hamilton RJ, Kulkarni GS, Ajib K, Nason G, Perlis N Tags: Can Urol Assoc J Source Type: research